KCNE1 and familial long QT syndrome: Taken together, although several KCNQ/KCNE1 activators have been reported, there are some limitations, including the low efficacy and the lack of specificity, that have to be overcome when thinking about the clinical use of these activators for the treatment of LQTS and cardiac arrhythmias.